Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease
- PMID: 20685658
- PMCID: PMC2943325
- DOI: 10.1074/jbc.C110.158303
Crystallographic studies of prion protein (PrP) segments suggest how structural changes encoded by polymorphism at residue 129 modulate susceptibility to human prion disease
Abstract
A single nucleotide polymorphism (SNP) in codon 129 of the human prion gene, leading to a change from methionine to valine at residue 129 of prion protein (PrP), has been shown to be a determinant in the susceptibility to prion disease. However, the molecular basis of this effect remains unexplained. In the current study, we determined crystal structures of prion segments having either Met or Val at residue 129. These 6-residue segments of PrP centered on residue 129 are "steric zippers," pairs of interacting β-sheets. Both structures of these "homozygous steric zippers" reveal direct intermolecular interactions between Met or Val in one sheet and the identical residue in the mating sheet. These two structures, plus a structure-based model of the heterozygous Met-Val steric zipper, suggest an explanation for the previously observed effects of this locus on prion disease susceptibility and progression.
Figures
Similar articles
-
Conformational diversity in prion protein variants influences intermolecular beta-sheet formation.EMBO J. 2010 Jan 6;29(1):251-62. doi: 10.1038/emboj.2009.333. Epub 2009 Nov 19. EMBO J. 2010. PMID: 19927125 Free PMC article.
-
Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.J Mol Biol. 2011 Sep 30;412(4):660-73. doi: 10.1016/j.jmb.2011.07.067. Epub 2011 Aug 4. J Mol Biol. 2011. PMID: 21839748
-
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.J Virol. 2014 Mar;88(5):2690-703. doi: 10.1128/JVI.02720-13. Epub 2013 Dec 18. J Virol. 2014. PMID: 24352465 Free PMC article.
-
An inherited prion disease with a PrP P105L mutation: clinicopathologic and PrP heterogeneity.Neurology. 1999 Jul 13;53(1):181-8. doi: 10.1212/wnl.53.1.181. Neurology. 1999. PMID: 10408557 Review.
-
Molecular approaches to mechanisms of prion diseases.Folia Neuropathol. 2004;42 Suppl A:33-46. Folia Neuropathol. 2004. PMID: 15449458 Review.
Cited by
-
Are Amyloid Fibrils RNA-Traps? A Molecular Dynamics Perspective.Front Mol Biosci. 2018 Jun 11;5:53. doi: 10.3389/fmolb.2018.00053. eCollection 2018. Front Mol Biosci. 2018. PMID: 29942805 Free PMC article.
-
Towards a pharmacophore for amyloid.PLoS Biol. 2011 Jun;9(6):e1001080. doi: 10.1371/journal.pbio.1001080. Epub 2011 Jun 14. PLoS Biol. 2011. PMID: 21695112 Free PMC article.
-
De novo design and experimental characterization of ultrashort self-associating peptides.PLoS Comput Biol. 2014 Jul 10;10(7):e1003718. doi: 10.1371/journal.pcbi.1003718. eCollection 2014 Jul. PLoS Comput Biol. 2014. PMID: 25010703 Free PMC article.
-
Human prion protein sequence elements impede cross-species chronic wasting disease transmission.J Clin Invest. 2015 Apr;125(4):1485-96. doi: 10.1172/JCI79408. Epub 2015 Feb 23. J Clin Invest. 2015. PMID: 25705888 Free PMC article.
-
A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.J Biol Chem. 2014 Apr 11;289(15):10660-10667. doi: 10.1074/jbc.M114.549030. Epub 2014 Mar 4. J Biol Chem. 2014. PMID: 24596090 Free PMC article.
References
-
- Palmer M. S., Dryden A. J., Hughes J. T., Collinge J. (1991) Nature 352, 340–342 - PubMed
-
- Mead S., Stumpf M. P., Whitfield J., Beck J. A., Poulter M., Campbell T., Uphill J. B., Goldstein D., Alpers M., Fisher E. M., Collinge J. (2003) Science 300, 640–643 - PubMed
-
- Kaski D., Mead S., Hyare H., Cooper S., Jampana R., Overell J., Knight R., Collinge J., Rudge P. (2009) Lancet 374, 2128. - PubMed
-
- Alperovitch A., Zerr I., Pocchiari M., Mitrova E., de Pedro Cuesta J., Hegyi I., Collins S., Kretzschmar H., van Duijn C., Will R. G. (1999) Lancet 353, 1673–1674 - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous